News
NOTVQ
0.048
-40.55%
-0.032
*News On Inotiv Inc. (NOTV) Now Under NOTVQ
Dow Jones · 9h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 2d ago
Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
Inotiv Secures DIP Financing Amid Bankruptcy and Delisting
TipRanks · 3d ago
*Inotiv: Nasdaq to Suspend Trading of Shares at Opening of Business June 11
Dow Jones · 3d ago
Inotiv enters USD 65.5 million superpriority DIP loan facility with lenders
PUBT · 3d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 3d ago
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Weekly Report: what happened at NOTV last week (0601-0605)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
Reuters · 6d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 6d ago
BUZZ-U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
Reuters · 6d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 06/04 17:06
BUZZ-U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
Reuters · 06/03 17:44
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 06/03 17:06
Inotiv files for bankruptcy in Texas
Seeking Alpha · 06/03 16:03
Inotiv Files for Chapter 11 Bankruptcy to Cut Debt by $326M
Dow Jones · 06/03 14:40
Inotiv Initiates Chapter 11 Restructuring to Overhaul Debt
TipRanks · 06/03 14:31
More
Webull provides a variety of real-time NOTVQ stock news. You can receive the latest news about Inotiv Inc through multiple platforms. This information may help you make smarter investment decisions.
About NOTVQ
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.